About N1 Precision

Built by a Father.
Driven by Necessity.

John Greer

Founder & Developer

CEO, Veda-Tegrity LLC

N1 Precision was born from the experience of a father navigating the relentless complexities of Dravet Syndrome with his son. After years of meticulously logging seizures, tracking medications, and searching for patterns in the data, one thing became painfully clear: the dartboard approach to dosing — adjusting medications based on guesswork and waiting to see what sticks — was not good enough.

There had to be a better way. A way grounded in data, in statistical rigor, and in the kind of analysis that gives caregivers and neurologists a real foundation for decision-making. That conviction became the driving force behind this platform.

With 26 years building professional software systems, John brings serious technical expertise to this work. This is not a weekend project — it's a carefully built system designed to be reliable for years to come, applied to the most personal problem of his life.

N1 Precision was built from day one to be reliable, secure, and able to grow with you. Automated database backups ensure your health data is protected and recoverable. The platform is built to grow with you — whether you are tracking for one patient or collaborating with a care team across multiple providers.

Philosophy

The Fundamentals Behind N1 Precision

Every feature in this platform is rooted in a set of core principles developed through years of real-world caregiving and data analysis.

01

Low & Slow Dosing Philosophy

Changing medications slowly, one step at a time, makes it much easier to see what's actually working. Fast changes make it hard to tell what caused what — so gradual adjustments give your data time to show real patterns.

02

Statistics as a Foundation

Keeping detailed records gives you something concrete to point to. Over time, the data can reveal patterns that are hard to see day-to-day — so you can have more productive conversations with your child's doctors.

03

Visualization of Complex Data

Your records become meaningful when you can see them. Interactive charts and visual timelines surface trends that would be invisible in a spreadsheet — from subtle seasonal patterns to the true impact of a medication change weeks after it was made.

04

Analytics Over Simplification

Epilepsy is complex, and the tools available must match that complexity. This tool is designed to handle the full picture — medications, triggers, patterns, context — because leaving things out means missing what matters.

05

Community Knowledge Sharing

Your data can help others facing the same battles. With opt-in data sharing, anonymized data from your tracking can help build a shared understanding of seizure patterns, how different medications worked, and environmental triggers — because no family should have to start from zero.

Technology

Built to Be Reliable and Secure

N1 Precision is powered by industry-leading technologies chosen for reliability, performance, and long-term maintainability.

Nuxt 4

Powers the app interface — fast, reliable, and works on any device.

MongoDB

Your data is stored in a secure database that's automatically backed up — so nothing is ever lost.

Claude AI

Powers the AI that reads your data and describes what it sees — so you can ask questions in plain language and get plain-language answers.

AWS Cognito

Your account is secured with healthcare-grade protections. Sign in with Google or email.

Tailwind CSS

Makes the app look clean and readable on phones, tablets, and desktops alike.

AWS Amplify

Hosted on Amazon Web Services cloud infrastructure with encryption at rest and in transit.

Vision

From Seizure Monster to N1 Precision

Eight years of continuous development, driven by a single conviction: the data families collect every day can reshape how epilepsy is understood and treated.

2017

Seizure Monster

A father sits down after another ER visit and writes the first seizure log. Built from scratch — because the paper seizure diary the neurologist handed them at diagnosis was failing.

2018

Beyond Logging

Seizure charts, cannabis product tracking, rescue medication management, and daily event triggers. The app grows from a log into an analytics tool because every new question demands a new feature.

2019

Patterns Emerge

Seizure cluster detection. Full moon correlation analysis. Seizure-free day badges. Calendar integration. Medication charts. The data starts revealing patterns that 15-minute appointments never could.

2020

Machine Learning

Software experiments to let the computer find patterns that human eyes miss. Multiple family members could now log data. The question shifts from "what happened" to "can software find the patterns human eyes miss?"

2021

Full Spectrum

Weather and barometric pressure analysis. Water tracking. Height/weight with dose-by-weight calculations. Quality of life scoring. The app grew to cover nearly every factor that could affect seizures.

2025

The Rebuild

Same database, same domain knowledge, modern architecture. Nuxt 4, Vue 3, Tailwind CSS, AI-powered analytics. The decision to rebuild from the ground up — not a migration, a reimagining.

2026

N1 Precision

Comprehensive analytics across two tiers. 4 products. Advanced analysis tools, interactive charts, and shared data that contributes to diagnosis-level cohort comparisons with consent. A platform that could reshape how epilepsy is tracked — and eventually understood.

The Gap It Exposed

Patients have more data than their doctors. A family managing severe epilepsy generates hundreds of data points per month. They bring this to a 15-minute appointment where the neurologist reviews a paper diary and makes a medication adjustment based on pattern recognition.

What if the patterns were computed, not remembered? What if medication response was a measurable curve? What if treatment similarity was a mathematical embedding? What if years of data could be compared — anonymously, with consent — against every other family with the same diagnosis?

The N-of-1

In clinical research, "N-of-1" describes a trial with a single participant — an experiment designed to determine the best treatment for one specific person.

That's what this platform does. It positions every patient as their own N-of-1 study subject. Their data is the evidence. Their medication changes are the interventions. Their seizure rates are the outcomes. The analytics are the analysis.

Traditional Medicine"What works for most people with this condition?"
N-of-1"What works for this person?"

Both questions matter. N1 Precision answers both — Insights and Clinical for the individual, Registry and Trials for the population.

For Patients & Families

A comprehensive analytics suite turns daily tracking into understanding. The AI doesn't diagnose — it summarizes what's in your data without telling you what to do. That's for you and your doctor together. The data belongs to the patient — not just in storage, but in access.

Bring Your Own AI

We believe your data belongs to you — which means you should be able to explore it with any tool you choose. That's why N1 Precision includes an agent-accessible API that lets you connect Claude, ChatGPT, or custom AI tools to your own health data. A pioneering capability we haven't found in any other epilepsy tracking platform.

For Clinicians

A neurologist managing 500 patients cannot track every trajectory from memory. N1 Precision Clinical gives them the rest of the picture — a window into the data the patient is already collecting, only what you choose to share, and only when you invite them.

For Researchers

Rare epilepsy studies struggle to find enough participants. N1 Precision Trials offers years of continuous, daily, patient-reported data — collected not for a study, but for life. The data researchers spend millions to collect already exists.

For the Community

Disease registries are the backbone of rare disease research. N1 Precision Registry inverts the model — patients use Insights because it helps them, and if they choose to share, they contribute to a living registry that grows automatically.

The Ecosystem

Four Products, One Platform

Each product builds on the last. Patient data flows from personal tracking through clinical review into research — always controlled by consent.

InsightsPatient tracking
ClinicalClinician view
TrialsResearch data
RegistryPopulation analytics

N1 Precision is not a medical device. It does not provide medical advice, diagnosis, or treatment recommendations. All analytical outputs are observational summaries of logged data and are not validated for clinical accuracy. Always consult a qualified healthcare provider.